Diabetic nephropathy is the leading cause of end-stage renal disease (ESRD). Cardiovascular (CV) complications are the most common cause of death among ESRD patients.
Beraprost sodium (BPS) is a prostacyclin analog with vasodilatory and anti-platelet effects.
Methods:
This is a multicenter…
Effect of beraprost sodium on arterial stiffness in patients with type 2 diabetic nephropathy
No comments:
Post a Comment